Evaluation of Mollugo oppositifolia Linn. as cholinesterase and β-secretase enzymes inhibitor

Evaluation of Mollugo oppositifolia Linn. as cholinesterase and β-secretase enzymes inhibitor

Mollugo oppositifolia Linn. is traditionally used in neurological complications. The study aimed to investigate in-vitro neuroprotective effect of the plant extracts through testing against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and β-secretase linked to Alzheimer’s disease (AD)....

Full description

Bibliographic Details
Main Authors: Bhaskar Das, Pardeep K. Bhardwaj, Nanaocha Sharma, Arnab Sarkar, Pallab Kanti Haldar, Pulok K. Mukherjee
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Pharmacology
Subjects:
molecular docking
Mollugo oppositifolia Linn.
Alzheimer’s disease
herb-drug interaction
safety evaluation
metabolite profiling and identification
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.990926/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.990926/full

Similar Items